Literature DB >> 1420810

Glycosaminoglycans in thyroid-associated ophthalmopathy.

G Kahaly1, C Stover, E Otto, J Beyer, M Schuler.   

Abstract

Glycosaminoglycan (GAG) accumulation in the retrobulbar space of patients with thyroid-associated ophthalmopathy (TAO) has been documented in a number of immunohistochemical studies. In order to gain further insight into possible immunopathogenic mechanisms, the influence of humoral immunity on retrobulbar fibroblasts (RF) as GAG producing cells as well as on GAGs themselves was investigated. The effect of lymphocytes on hyaluronic acid (HA) synthesis of RF as well as in turn the influence of RF on lymphocytes were evaluated. In search of methods which would facilitate management of patients with TAO and allow assessment of disease activity, GAGs were determined in both urine and plasma. Immunoglobulin G (IgG) of patients with TAO were found to markedly stimulate the 3H-GAG secretion of RF. Patients with TAO exhibited significantly greater antibody values directed against HA than controls. Preliminary results concerning the influence of lymphocytes on RF indicate a tendency for patients' lymphocytes to increase the synthesis of HA. Furthermore, these lymphocytes in turn were stimulated more by irradiated autologous RF than by irradiated heterologous RF. Urine and plasma GAG determination proved to be suitable for the routine assessment of disease activity and outcome of therapy. In conclusion, GAGs seem to play an important role in the pathogenesis of the disease and their measurement may provide aid to the endocrinological evaluation of patients with TAO.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420810     DOI: 10.3109/08916939209014639

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

1.  Analysis of orbital T cells in thyroid-associated ophthalmopathy.

Authors:  G Förster; E Otto; C Hansen; K Ochs; G Kahaly
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 2.  [Endocrine orbitopathy 1998].

Authors:  G Förster; G Kahaly
Journal:  Med Klin (Munich)       Date:  1998-06-15

3.  Plasma glycosaminoglycans in endocrine ophthalmopathy.

Authors:  G Kahaly; C Hansen; J Beyer; R Winand
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

4.  Quantitative determination of glycosaminoglycans in tears of diabetic patients.

Authors:  Marilita M Moschos; Alexandros A Rouvas; Spyridon Papadimitriou; Athanasios Kotsolis; Nikolaos Sitaras; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-09

5.  Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy.

Authors:  Tom McCorquodale; Hooshang Lahooti; Bamini Gopinath; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2012-07-12

6.  [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; G Gusek-Schneider; S Barth; J Hensen; F Wolf; G O Naumann; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 4.033

Review 7.  Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.

Authors:  Thayalini Shanmuganathan; Christian Girgis; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2015-12-03

Review 8.  Thyrotropin receptor antibodies and Graves' orbitopathy.

Authors:  T Diana; K A Ponto; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2020-08-04       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.